This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cleophas, T. J. M. Articles by van der Meulen, J. Search for Related Content PubMed PubMed Citation Articles by Cleophas, T. J. M. Articles by van der Meulen, J. Social Bookmarking                         What's this?

Nitrate-Induced Headache in Patients with Stable Angina Pectoris: Beneficial Effect of Starting on a Low Dosage

Departments of Medicine and Cardiology, University Hospital Groningen, University Hospital Leiden, Free University Hospital Amsterdam, Merwede Hospital Dordrecht, the Netherlands

Menco G. Niemeyer

Departments of Medicine and Cardiology, University Hospital Groningen, University Hospital Leiden, Free University Hospital Amsterdam, Merwede Hospital Dordrecht, the Netherlands

Ernst E. van der Wall

Departments of Medicine and Cardiology, University Hospital Groningen, University Hospital Leiden, Free University Hospital Amsterdam, Merwede Hospital Dordrecht, the Netherlands

Jan van der Meulen

Departments of Medicine and Cardiology, University Hospital Groningen, University Hospital Leiden, Free University Hospital Amsterdam, Merwede Hospital Dordrecht, the Netherlands

Background: Nitrates, although important for the management of angina pectoris, cause significant headache in many patients.

Methods: In a randomized, double-blind, crossover study, 89 patients with stable angina pectoris were studied to compare two different dosage strategies of isosorbide-5-monon itrate (5-ISMN). Patients were randomized to either 60 mg 5-ISMN once daily (od) for two weeks or to 30 mg 5-ISMN od for one week followed by 60 mg 5-ISMN od for one week. Then, there was a two-week placebo washout, after which the alternative treatment was given. The authors assessed the occurrence of angina pectoris and headache by diary cards while taking into account the numbers of isosorbide dinitrate sublingual puffs and paracetamole tablets required. Data were assessed for carryover and time effects.

Results: The two dosage regimens were equally efficient for the relief of angina pectoris without development of tolerance. Thirty percent of the patients never experienced headache from the given dosages. In the remainder of them there was a highly significant time effect: the overall numbers of headache attacks in the first period of active treatment versus the second were 2,380 vs 1,400 (P < 0.003). Yet significantly fewer patients had headache on low dosage than on high dosage (45 vs 57, P < 0.02).

Conclusions: (1) Starting on a low dosage was associated with a reduced frequency and severity of headache and did not notably influence the beneficial effect on angina pectoris. (2) One in 3 patients never experienced headache from the given dosages. (3) The overall number of headache attacks in the first period of active treatment was signif icantly higher than in the second period irrespective of the dosages given.

Angiology, Vol. 47, No. 7, 679-685 (1996)
DOI: 10.1177/000331979604700707


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?